Trial Profile
Assessment of Duration of Metabolic Effect of a Single Bolus of Subcutaneous Injected Lantus [insulin glargine] Compared to NPH-Insulin (Protaphan) [insulin suspension isophane] in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 16 Nov 2007 New trial record.